Basaglar 100 Unit (Insulin Glargine SOLUTION) 100 UNIT

BASAGLAR 100 Unit is a long-acting insulin glargine solution for subcutaneous use, designed to help manage blood sugar levels in diabetes care. This medication is manufactured by Eli Lilly Canada Inc. and is suitable for daily administration.

Strength

100 UNIT

Manufacturer / TM Owner

ELI LILLY CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

BASAGLAR 100 Unit is primarily used for the management of diabetes, helping to control blood sugar levels over a prolonged period. It is often prescribed as part of a comprehensive diabetes treatment plan, which may include diet and exercise. This insulin glargine solution is intended for subcutaneous injection, typically once a day, to provide consistent insulin coverage throughout the day and night.

Side Effects

Common effects of BASAGLAR 100 Unit may include mild to moderate reactions at the injection site, such as redness, swelling, or itching. Some users may experience hypoglycemia, characterized by symptoms like sweating, dizziness, or confusion. It is important to monitor blood sugar levels regularly while using this medication to ensure it is working effectively.

Precautions & Warnings

BASAGLAR 100 Unit should be stored properly to maintain its effectiveness. Keep it refrigerated and protect it from light and heat. Always check the solution for particles or discoloration before use. If you notice any changes, do not use the medication. It is also important to follow the administration instructions provided by your healthcare professional to ensure safe and effective use.

Avoid Interactions

BASAGLAR 100 Unit may interact with other medications, including oral hypoglycemic agents, corticosteroids, and certain antidepressants. Alcohol consumption can also affect blood sugar levels and should be monitored carefully. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.

Frequently Asked Questions

BASAGLAR 100 Unit is used to manage blood sugar levels in individuals with diabetes, providing long-acting insulin coverage.

BASAGLAR 100 Unit is administered subcutaneously, typically once a day, as part of a diabetes management plan.

Common side effects may include injection site reactions and hypoglycemia, characterized by symptoms like sweating and dizziness.

BASAGLAR 100 Unit should be stored refrigerated and protected from light and heat. Always check the solution for particles or discoloration before use.

Yes, BASAGLAR 100 Unit may interact with oral hypoglycemic agents, corticosteroids, and certain antidepressants. Always inform your healthcare provider about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.